id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-337204-14gxpeaf	Piciucchi, Matteo	Preliminary considerations regarding the risk of COVID-19 and disease severity in chronic gastrointestinal conditions	2020-05-25		.txt	text/plain	1637	90	43	Since the discovery of SARS-CoV-2 at the end of 2019, several studies of the epidemiology, risk factors, clinical findings, therapy and virological features of this infection have become available and are totally free to clinicians via a PubMed search [1, 2] . In particular, several risk factors that are involved in acquiring the infection and that affect the clinical course and severity of COVID-19related diseases have been identified (Figure 1 ), but conclusive data are still lacking [2, 4] . As far as inflammatory bowel disease (IBD) is concerned, there are no data to suggest a higher risk of SARS-CoV-2 infection or a higher severity of related diseases in these patients, compared to the general population. More specifically, prospective studies to analyze the risk of the infection and its possible course in patients with IBD, pancreatitis and liver diseases are needed in order to improve care for these patients.	./cache/cord-337204-14gxpeaf.txt	./txt/cord-337204-14gxpeaf.txt